Skip to content
healthcare.dev

Deferasirox

NDC 43598-852, Deferasirox, tablet, from Dr. Reddy's Laboratories Inc.

Product NDC
43598-852
Status
Listed
Labeler
Dr. Reddy's Laboratories Inc
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA210945
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/43598-852 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEFERASIROX180 mg/1

Pharmacologic classes

Cytochrome P450 1A2 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Iron Chelating Activity [MoA]; Iron Chelator [EPC]

Package NDCNDC-11Package
43598-852-10435980852101000 TABLET in 1 BOTTLE (43598-852-10)
43598-852-304359808523030 TABLET in 1 BOTTLE (43598-852-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/350dfc39-d03d-e221-22e9-3880728c955c

Use it

Look up 43598-852 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/43598-852 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 43598-852. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.